Drugs / MINHAI PCV13
MINHAI PCV13
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02494999 | Jun 2016 → Dec 2018 | pneumonia | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2025-02-28 | BioNet-Asia Co., Ltd. | Results Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria bionet-asia.com ↗
We now report on safety and antibody responses to childhood vaccination with diphtheria-tetanus-whole cell pertussis (DTwP) and 13-valent pneumococcal conjugate vaccine (PCV13) in these infants until 13 months of age according to pertussis vaccine the mother received in pregnancy. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2025-02-28 | BioNet-Asia Co., Ltd. | Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria bionet-asia.com ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MINHAI PCV13 | “A phase 3 clinical trial of MINHAI PCV13 in Chinese children aged from 7 months to 5 years old.” PMID 34706841 ↗ Oct 2021 |
| Known as | 13-valent pneumococcal conjugate vaccine | “A new 13-valent pneumococcal conjugate vaccine (PCV13) with carrier tetanus toxoid and diphtheria toxoid was developed by MINHAI, aiming to prevent pneumococcus infection.” PMID 34706841 ↗ Oct 2021 |
| Known as | PCV13 | “A new 13-valent pneumococcal conjugate vaccine (PCV13) with carrier tetanus toxoid and diphtheria toxoid was developed by MINHAI, aiming to prevent pneumococcus infection.” PMID 34706841 ↗ Oct 2021 |
| Modality | Vaccine | “A new 13-valent pneumococcal conjugate vaccine (PCV13)” PMID 34706841 ↗ Oct 2021 |
| Route | Intramuscular | “Single 0.5 ml dose will be given via intramuscular injection in Month 0,2,4 and 10” NCT02494999 ↗ |